AnandRathi

Beryl Drugs Ltd Fundamental Analysis

Last Updated Date: 21 Sept 2026
23.90
+0.21 (+0.89%)

Beryl Drugs Ltd (Beryl Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹12 crore.

Beryl Drugs Ltd Overview

Market cap₹12 Crs
Volume1,508
Prev. Close₹23.69
Year range₹15.92 - ₹27.60
ISININE415H01017

Beryl Drugs Ltd Fundamentals

ROCE(TTM)7.56%
P/E Ratio (TTM)19.43
P/B Ratio1.23
Debt to Equity0.25
ROE4.30%
EPS (TTM)1.23
Dividend Yield0.00%
Book Value19.44
Profit Margin2.91%
Operating Margin4.94%

Beryl Drugs Ltd Historical Performance

1 Month Return4.82%
6 Month Return11.68%
3 Year Return8.69%
3 Month Return9.58%
1 Year Return6.65%
5 Year Return91.35%

Beryl Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research